O. Brodsky

Insights into the aberrant activity of mutant EGFR kinase domain and drug recognition.

K. Gajiwala, K. Ryan, A. Stewart, 2013, Structure.

Targeting Divalent Metal Ions at the Active Site of the HIV-1 RNase H Domain: NMR Studies on the Interactions of Divalent Metal Ions with RNase H and Its Inhibitors

Jiangli Yan, K. Maegley, O. Brodsky, 2011 .

Crystal Structure of a Novel Dimeric Form of NS5A Domain I Protein from Hepatitis C Virus (cid:1)

M. Hickey, P. A. Wells, O. Brodsky, 2009 .

Proteome-wide Map of Targets of T790M-EGFR-Directed Covalent Inhibitors.

K. Gajiwala, Sherry L. Niessen, B. Cravatt, 2017, Cell chemical biology.

Crystal Structure of a Novel Dimeric Form of NS5A Domain I Protein from Hepatitis C Virus

M. Hickey, P. A. Wells, O. Brodsky, 2009, Journal of Virology.

Economical parallel protein expression screening and scale-up in Escherichia coli

O. Brodsky, C. Cronin, 2007, Journal of Structural and Functional Genomics.

Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer.

Chin Wee Tan, Dharmesh D. Bhuva, Eric C Greenwald, 2023, Cell chemical biology.

Crystal Structure of a Novel Dimeric Form of NS5A Domain I Protein from Hepatitis C Virus

M. Hickey, P. A. Wells, O. Brodsky, 2009, Journal of Virology.